Press Releases

New Lyphochek® Allergen sIgE Controls

HERCULES, CA – August 1, 2015 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announced the release of human-serum based Lyphochek® Allergen sIgE quality controls to monitor precision of in vitro allergy test procedures.

 

Bio-Rad Laboratories announces the launch of Liquichek Maternal Serum 1st Trimester Control

HERCULES, CA – November, 2013 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announces the launch of Liquichek™ Maternal Serum 1st Trimester Control.

 

Bio-Rad Laboratories Expands Their EQAS Offering with Three New Programs

HERCULES, CA – January 11, 2013 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announces the release of three External Quality Assurance Service (EQAS®) Programs for clinical laboratories and near patient/POC settings around the world. The new programs are: Cardiac Markers, Ethanol/Ammonia, and Lipids.

 

Bio-Rad Introduces EQAS Mobile, an Easy Way for Clinical Labs to Submit Proficiency Testing Results Using a Smartphone

HERCULES, CA – January 10, 2013 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, today announced the launch of its EQAS® Mobile (External Quality Assurance Service) that offers clinical laboratories the ability to use an iPhone® or Android™ smartphone to configure and submit their proficiency testing results to Bio-Rad’s QCNet™ online portal (www.QCNet.com/eqasonline).

 

Bio-Rad Laboratories launches the EQAS Coagulation Program

HERCULES, CA – October 25, 2012 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, today announced the release of External Quality Assurance Service (EQAS) Coagulation Program for clinical laboratories around the world.

 

Bio-Rad Laboratories launches the EQAS Blood Gas Program

HERCULES, CA – October 25, 2012 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products today announced the release of its External Quality Assurance Service (EQAS) Blood Gas Program.

 

Bio-Rad Introduces Liquichek Whole Blood Immunosuppressant Control

HERCULES, CA – October 17, 2012 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostics products, announces the release of Liquichek™ Whole Blood Immunosuppressant Control. This third party, human whole blood based product is designed for use as an assayed quality control material to monitor the precision of immunosuppressant drug testing procedures in the clinical laboratory. Its liquid formulation is suitable for use with immunoassay and chromatographic techniques.

 

Siemens and Bio-Rad Extend Joint Marketing Agreement for IMMULITE and Dimension Systems to Further Optimize Efficiency and Data Reliability

Tarrytown, NY and Hercules, Calif., December 13, 2011 – Today, Siemens Healthcare Diagnostics and
Bio-Rad Laboratories, Inc. announced an expansion of a global joint marketing agreement in which
Bio-Rad will provide its quality control (QC) products and Unity™ data management solutions for Siemens' IMMULITE® Immunoassay, Dimension® Integrated Chemistry and Dimension Vista® Intelligent Lab systems. This move extends clinical laboratories' access to Bio-Rad's consistent control product and data management tools within the Siemens clinical laboratory systems portfolio which, until today, were only available through Siemens' ADVIA® Chemistry and ADVIA Centaur® Immunoassay systems.

 

Bio-Rad Introduces New And Improved Liquichek™ Specialty Immunoassay Control

HERCULES, CA – October 15, 2010 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of the enhanced Liquichek™ Specialty Immunoassay Control.

 

Bio-Rad launches elnserts™ XML, an innovative solution to load assay values directly into instruments

HERCULES, CA – May 17, 2010 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multinational manufacturer and distributor of life science research products and clinical diagnostics, today announced the launch of eInserts™ XML, an online service which allows laboratories to generate an XML file with assay values for Bio-Rad quality control products and import the data directly into their instruments.

 

Bio-Rad Introduces Liquichek Opiate Control

HERCULES, CA – April 12, 2010 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multi-national manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of Liquichek™ Opiate Control. Liquichek Opiate Control is a liquid, third party control designed to monitor urine toxicology testing procedures for a broad class of opioids.

 

Bio-Rad Introduces Liquichek Hematology and Reticulocyte Controls for Sysmex Hematology Instruments

HERCULES, CA – March 22, 2010 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multi-national manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of Liquichek™ Hematology Control (X) and Liquichek™ Reticulocyte Control (X). The two products are the latest additions to the growing family of hematology controls from Bio-Rad and are designed to monitor the precision of hematology parameters on Sysmex systems.

 

BIO-RAD Introduces Liquichek Hematology and Reticulocyte Controls for Abbott CELL-DYN Sapphire and CELL-DYN 4000 Instruments

HERCULES, CA – February 22, 2009 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multi-national manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of Liquichek™ Hematology Control (A-I) and Liquichek™ Reticulocyte Control (A-I). These two new products are designed to monitor the precision of hematology parameters on Abbott CELL-DYN® Sapphire and CELL-DYN 4000 systems.

 

BIO-RAD Introduces Liquichek Hematology and Reticulocyte Controls for Siemens ADVIA Instruments

HERCULES, CA – January 26, 2009 – Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a multi-national manufacturer and distributor of life science research and clinical diagnostic products, today announced the launch of Liquichek™ Hematology Control (S) and Liquichek Reticulocyte Control (S). These two new products are designed to monitor the precision of hematology parameters on Siemens ADVIA® systems.

 

Find Products & Information

Log In / Register

Log In / Register
PLEASE LOG IN NOT REGISTERED?
Login ID
Password
  

1

Blood Gas Program

Blood Gas Program
EQAS Blood Gas Program is a monthly external quality assessment program for the reporting of routine blood gas, electrolytes, glucose, lactate and magnesium by blood gas, ion selection electrode (ISE) and biosensor instrumentation.
  • Liquid, aqueous samples
  • Comprehensive menu for external assessment of laboratory performance of Blood Gas, Electrolytes, Glucose, Lactate and Magnesium
  • 12-month cycle
Analytes
Calcium (Ionized) 
Chloride
Glucose
Lactate (Lactic Acid)
Magnesium
pH
pCO2
pO2
Potassium
Sodium


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
February 26, 2014: Results outside the assay range & UR Codes

Catalog Number
BC31

Kit Configuration
12x2.5mL

Order/Enroll »

Insert »

Clinical Chemistry (Monthly) Program

Clinical Chemistry (Monthly) Program
EQAS Clinical Chemistry (Monthly) Program is an external quality assessment program for general chemistries and thyroids. Samples are tested and data submitted only once-per-month. Monthly reports provide informative statistical analyses and valuable peer group comparisons.
  • Lyophilized, human serum based
  • 12-month cycle
  • Submit results for the appropriate sample every month
  • Reference Method Values available for parameters in green.
Analytes
Acid Phosphatase (Total)
Alanine Aminotransferase
(ALT/SGPT)
Albumin
Alkaline Phosphatase (ALP)
Amylase (Pancreatic)
Amylase (Total)
Aspartate Aminotransferase
(AST/SGOT)

Bile Acid (Pilot Analyte)
Bilirubin (Direct)
Bilirubin (Indirect) (Pilot Analyte)
Bilirubin (Total)
Calcium (Ionized)
Calcium (Total)
Carbon Dioxide (CO2)
Chloride
Cholesterol (HDL)
Cholesterol (LDL)
Cholesterol (Total)
Cholinesterase
Copper
Cortisol
Creatine Kinase (CK)
Creatinine
Gamma Glutamyl
Transferase (GGT)
Glucose
Iron
Iron Binding Capacity,
Total (TIBC)
Iron Binding Capacity,
Unsaturated (UIBC)
Lactate
Lactate Dehydrogenase
(LDH)
Lipase
Lithium
Magnesium
Osmolality
Phosphorus
Potassium
Protein (Total)
Sodium
Thyroid Stimulating Hormone
(TSH)
Thyroxine (FT4), Free Thyroxine (T4), Total
Transferrin (Pilot Analyte)
Triglycerides
Triiodothyronine (FT3), Free Triiodothyronine (T3),Total
Urea
Urea Nitrogen
Uric Acid
Zinc


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Catalog Number
BC50

Kit Configuration
12x5mL

Order/Enroll »

Insert »

Ref. Method Values »

Cardiac Markers Program

Cardiac Markers Program
EQAS Cardiac Markers Program is a monthly external quality assessment program for assessing cardiac health including D-dimer, that are tested in clinical labs and near patient/POC settings worldwide.
  • Liquid, human plasma based
  • Comprehensive menu of important cardiac assessment markers, plus D-dimer
  • 12-month cycle
Analytes
BNP
CK-MB
D-dimer
Homocysteine
hs-CRP
Myoglobin
NT-proBNP
Troponin I
Troponin T


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Catalog Number
BC39

Kit Configuration
12x1.5mL

Order/Enroll »

Insert »

Coagulation Program

Coagulation Program
EQAS Coagulation Program is an external quality assessment program designed for the quantitative measure of basic coagulation parameters, including Protein C and Protein S Activity. Twelve plasma samples are tested over the course of an annual cycle and results submitted once per month.
  • Lyophilized, human plasma based
  • 8 parameters for external assessment of laboratory coagulation test performance
  • 12-month cycle
  • Choice of program size to suit your needs
  • Option to submit results electronically and view reports online at QCNet.com
Analytes
Antithrombin III (ATIII)
APTT
D-dimer
Fibrinogen
INR
Protein C
Protein S
PT
Thrombin Time (TT)


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
February 26, 2014: Results outside the assay range & UR Codes

Catalog Number
BC34

Kit Configuration
12x1mL

Order/Enroll »

Insert »

Ethanol/Ammonia Program

Ethanol/Ammonia Program
EQAS Ethanol/Ammonia Program is an international, monthly, external quality assessment program containing levels of ethanol and ammonia in serum that span normal to abnormal (or toxic) ranges.
  • Liquid, human serum based
  • Clinically relevant levels of serum Ethanoland Ammonia
  • 12-month cycle
  • Submit results for the appropriate sample every month
  • Option to submit results electronically and view reports online at QCNet.com
Analytes
Ammonia
Ethanol


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
None Available

Program Dates ( Cycle Number - Sample Number : Due Date )

Catalog Number
BC35

Kit Configuration
12x3mL

Order/Enroll »

Insert »

Hemoglobin Program

Hemoglobin Program
Analytes
Hemoglobin A1C
Hemoglobin A2
Hemoglobin (Total Glycated)


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
February 26, 2014: Results outside the assay range & UR Codes

Catalog Number
BC80

Kit Configuration
12x0.5mL

Order/Enroll »

Insert »

Ref. Method Values »

Immunoassay (Monthly)

Immunoassay (Monthly)
EQAS Immunoassay (Monthly) Program is a comprehensive program covering 57 of the most commonly tested immunoassay analytes including endocrinology, thyroid function, oncology and therapeutic drugs. Samples are tested and results submitted once-per-month. Regular reports provide informative statistical analyses and valuable peer group comparisons
  • Lyophilized, human serum based
  • Comprehensive menu of the most commonly tested immunoassay analytes
  • 12-month cycle
  • Submit results for the appropriate sample every month
Analytes
11-Deoxycortisol
17-α-OH-Progesterone
25-OH Vitamin D
β-2 Microglobulin
ACE
ACTH
Aldosterone
Alphafetoprotein (AFP)
Androstenedione
C-Peptide
CA 15-3
CA 19-9
CA 27-29
CA 125
Carbamazepine Carcinoembryonic Antigen
(CEA)
Cortisol
DHEA
DHEA Sulfate
Digoxin
Estradiol
Estriol, Free (UE3)
Ferritin
Folate
Follicle Stimulating Hormone
(FSH)
Gastrin
hCG
hGH
Immunoglobulin E (IgE)
Insulin Intact PTH
LH
NSE
Phenobarbital
Phenytoin
Plasma Renin Activity
Progesterone
Prolactin
PSA (Free)
PSA (F/T Ratio)
PSA (Total)
Renin
S100 Protein
Sex Hormone Binding
Globulin (SHBG)
T3 Uptake
T-Uptake
Testosterone
Theophylline
Thyroxine Stimulating
Hormone (TSH)
Thyroxine Binding Globulin
(TBG)
Thyroxine, Free (FT4)
Thyroxine (T4), Total
Transferrin
Triiodothyronine, Free (FT3)
Triiodothyronine (T3), Total
Valproic Acid
Vitamin B12
Thyroglobulin(Pilot analyte)
Testosterone,Free (Pilot analyte)




User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
February 26, 2014: Results outside the assay range & UR Codes

Catalog Number
BC75

Kit Configuration
12x5mL

Order/Enroll »

Insert »

Lipids Program

Lipids Program
EQAS Lipids Program is a monthly external quality assessment program containing serum analytes for a full range of lipid profile.
  • Liquid, human serum based
  • Comprehensive menu of lipid profile analytes
  • 12-month cycle
  • Submit results for the appropriate sample every month
Analytes
Apolipoprotein A-1
Apolipoprotein B
Cholesterol (HDL)
Cholesterol (LDL)
Cholesterol (Total)
Lipoprotein (a)
Triglycerides
Pilot Analyte
Cholesterol (non-HDL)


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
None Available

Catalog Number
BC47

Kit Configuration
12x3mL

Order/Enroll »

Insert »

Serum Protein Programs

Serum Protein Programs
EQAS Serum Protein Programs is an external quality assessment program for testing specific serum proteins, including kappa and lambda light chains. Samples are tested and results submitted each month. Regular reports provide informative statistical analyses and valuable peer group comparisons.
  • Lyophilized, human serum based
  • Comprehensive menu for external assessment of serum protein assays
  • 12-month cycle
  • Submit results for the appropriate sample every month
Analytes
α-1 Acid Glycoprotein
α-1 Antitrypsin
α-2 Macroglobulin
Β-2 Microglobulin
Albumin
Antistreptolysin O (ASO)
C-Reactive Protein (CRP)
Ceruloplasmin
Complement C3
Complement C4
Haptoglobin
Immunoglobulin A (IgA)
Immunoglobulin E (IgE)
Immunoglobulin G (IgG)
Immunoglobulin M (IgM)
Kappa Light Chain
Lambda Light Chain
Prealbumin
Protein (Total)
Rheumatoid Factor (RF)
Transferrin


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Catalog Number
BC23

Kit Configuration
12x0.5mL

Order/Enroll »

Insert »

Therapeutic Drug Monitoring Program

Therapeutic Drug Monitoring Program
EQAS Therapeutic Drug Monitoring Program is an external quality assessment program for monitoring up to 21 analytes. Participants submit results each month and receive regular reports with informative statistical analyses and valuable peer group comparisons.
  • Lyophilized, human plasma based
  • Analytes targeted at therapeutic, sub-therapeutic and toxic levels
  • 12-month cycle
  • Submit results for the appropriate sample every month
  • Weighed-in Values provided for select analytes at end of cycle
Analytes
Acetaminophen
Amikacin
Amitriptyline
Caffeine
Carbamazepine
Cyclosporine
Digoxin
Ethosuximide
Gentamicin
Lithium
Methotrexate
Nortriptyline
Phenobarbital
Phenytoin
Primidone
Salicylate
Theophylline
Tobramycin
Tricyclic Antidepressants
(TCA) Screen
Valproic Acid
Vancomycin


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
None Available

Catalog Number
BC10

Kit Configuration
12x5mL

Order/Enroll »

Insert »

Weighed-in-Values »

Tumor Marker -- DISCONTINUED

Tumor Marker -- DISCONTINUED
EQAS Tumor Marker Program is an international external quality assessment program offering key tumor markers, including the important myeloma maker, S-100 Protein. Twelve samples are tested over the course of an annual cycle and results submitted once per month.
  • Lyophilized, human serum based
  • Comprehensive list of analytes at normal and abnormal levels
  • 12-month cycle
  • Submit results for the appropriate sample every month
  • Option to submit results electronically and view reports online at QCNet.com
Analytes
ACTH
Alphafetoprotein (AFP)
CA 15-3
CA 19-9
CA 27 .29
CA 125
Carcinoembryonic Antigen (CEA)
hCG
NSE
PSA (Free)
PSA (Free/Total Ratio)
PSA (Total)
S100 Protein




User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
December 5, 2012: IMPORTANT NOTICE - Z-Score Limits Lowered to 3.0

Program Dates ( Cycle Number - Sample Number : Due Date )
JAN FEB MAR APR MAY JUN
40 - 12 : 13
 
JUL AUG SEPT OCT NOV DEC

Catalog Number
BC24 • QC24

Kit Configuration
12x1mL

Insert »

Urine Chemistry Program

Urine Chemistry Program
EQAS Urine Chemistry Program is a comprehensive matrix appropriate program offering up to 24 of the most commonly tested basic and specialty urine chemistry analytes. Samples are tested once-per-month. Laboratories will receive informative monthly end-of-cycle reports providing statistical analyses and valuable peer group comparisons.
  • Lyophilized, human urine based
  • Matrix appropriate samples include basic and specialty urine chemistry analytes
  • 12-month cycle
  • Choice of program size to suit your needs
Analytes
5-Hydroxyindoleacetic
Acid (5-HIAA)
Aldosterone
Calcium (Total)
Chloride
Cortisol (Free)
Creatinine
Dopamine
Epinephrine
Glucose
Homovanillic Acid (HVA)
Hydroxyproline (Total)
Magnesium
Metanephrine
Microalbumin/Albumin
Norepinephrine
Normetanephrine
Osmolality
Phosphorus
Potassium
Protein (Total)
Sodium
Urea (Pilot analyte)
Urea Nitrogen
Uric Acid
Vanillylmandelic Acid (VMA)


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
None Available

Catalog Number
BC45

Kit Configuration
12x10mL

Order/Enroll »

Insert »

EQAS Quality Specification Report

EQAS Quality Specification Report

As an international EQA provider, Bio-Rad determines the acceptable performance of a laboratory participating in their EQAS® Program. Performance of each reported test result is based on a statistical comparison to a robust mean and standard deviation. The use of robust statistics based on ISO 13528 and assessment against a consensus group mean are widely accepted practices used in many ISO 17043 accredited programs.

Globally, a number of regulatory bodies and scientific organizations have independently determined acceptable performance criteria(quality specifications)for a number of key laboratory tests.These are based on Biological Variation, regulatory or scientific recommendations.

In the new EQAS® Quality Specification Report, a laboratory may assess their EQA test performance based on the quality specification of their choice. Performance in this report is based on the percent deviation of the reported test result. This value-added report is only available through EQAS® Online. A laboratory may generate their EQAS® Quality Specification Report for each sample reported on. It does not replace the EQAS® Sample Report.

Bio-Rad will initially offer Biological Variation (BV) limits (minimal, desirable and optimal), CLIA proficiency limits, RiliBÄK, RCPA, IQMH and GOST criteria for acceptable analytical performance in the EQAS® Quality Specification Report. Additional performance criteria (quality specifications) and guidelines will follow.


Download Flyer »

Hematology Program

Hematology Program
EQAS Hematology Program is an international external assessment program for satisfying your basic hematology testing needs. Samples are provided in the convenience of liquid form in pierceable primary tubes and are to be tested on a monthly frequency. Valuable peer group and statistical comparisons are provided for each sample.
  • Liquid product with human RBCs
  • Choice of 11 basic hematology parameters
  • For use on manual or automated analyzers
  • Convenience of primary pierceable tubes
  • 12-month cycle consisting of 4 separate shipments
  • Submit results for the appropriate sample every month
Analytes
Hematocrit (HCT)
Hemoglobin
Mean Corpuscular Hemoglobin (MCH)
Mean Corpuscular Hemoglobin
Concentration (MCHC)
Mean Corpuscular Volume (MCV)
Mean Platelet Volume (MPV)
Platelets (PLT)
Red Blood Cells (RBC)
Red Blood Cell Distribution Width (RDW)
Red Blood Cell Distribution Width
(RDW-SD)
White Blood Cells (WBC)




User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
N/A



Catalog Number
BC90A • BC90B • BC90C • BC90D

Kit Configuration
3x2mL

Order/Enroll »

Insert »

HIV/Hepatitis Program

HIV/Hepatitis Program
EQAS HIV/Hepatitis Program is suitable for serological tests used to detect key HIV and Hepatitis viral antibodies and antigens.
  • Liquid, human source material
  • Suitable for serological tests used to detect key HIV and Hepatitis viral antibodies and antigens
  • A qualitative and quantitative program is available
  • Submit results and view reports each month through EQAS Online
  • 12 x 2 mL
Analytes
Anti-HAV
Anti-HAV IgG
Anti-HAV IgM
Anti-HBc
Anti-HBc IgM
Anti-HBe
Anti-HBs
Anti-HCV
Anti-HIV-1
Anti-HIV-1/2
Anti-HIV-2
Anti-HTLV-I
HBeAg
HBsAg
HIV-1 Ag


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications

Catalog Number
12000815

Kit Configuration
12 x 2 mL

Insert »

Blood Typing Program

Blood Typing Program
EQAS Blood Typing Program
  • Ideal for clinical lab, blood bank and transfusion center testing needs
  • Barcoded and ready-to-use tubes for automated platforms
  • 3 samples tested every 4 months
  • Submit results and view reports through EQAS Online
  • 3x4 mL Sample and 1x2 mL Donor(eachshipment)
Parameters
ABO Group
Antibody Identification
Antibody Screen

Compatibility (Cross-match)
DAT (Direct Antiglobulin Test)
Rh(D)

Pilot Analyte
Antigen Typing
 

1Aspects of the program are subcontracted from an approved supplier..

User Documentation
Please log in to view content.

Customer Notifications
Please log in to view content.

Catalog Number
12000837 Shipment A
12000838 Shipment B
12000839 Shipment C

Kit Configuration
3x4 mL (Sample) + 1x2 mL (Donor)

Order/Enroll »

Insert »

Syphilis Program

Syphilis Program
EQAS Syphilis Program
  • Liquid, human source material
  • Suitable for serological tests detecting treponemal and non-treponemal antibodies
  • 12-month cycle
  • A qualitative and quantitative program is available
  • Submit results and view reports each month through EQAS Online
  • 12x1.5mL
Analytes
Non-Treponemal antibodies
Treponema pallidum IgG
Treponema pallidum IgM
Treponema pallidum Antibodies


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications

Catalog Number
12000833

Kit Configuration
12 x 1.5 mL

Insert »

ToRCH/EBV/MuMZ Program

ToRCH/EBV/MuMZ Program
EQAS ToRCH/EBV/MuMZ Program
  • Liquid, human source material
  • Suitable for serological tests used to detect pediatric diseases and congenital infections • A qualitative and quantitative program is available
  • Submit results and view reports each month through EQAS Online
  • 12x2mL
Analytes
Cytomegalovirus (CMV) IgG
Cytomegalovirus (CMV) IgM
Epstein-Barr Virus (EBNA) IgG
Epstein-Barr Virus (VCA) IgG
Epstein-Barr Virus (VCA) IgM
Herpes Simplex Virus (HSV-1) IgG
Herpes Simplex Virus (HSV-1/2) IgG
Herpes Simplex Virus (HSV-2) IgG
Measles Virus (Rubeola) IgG
Mumps Virus IgG
Rubella Virus IgG
Rubella Virus IgM
Toxoplasma gondii (Toxo) IgG
Toxoplasma gondii (Toxo) IgM
Varicella Zoster Virus (VZV) IgG


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications

Catalog Number
12000825

Kit Configuration
12 x 2 mL

Insert »

Urinalysis Program

Urinalysis Program
EQAS Urinalysis Program
  • Lyophilized, human urine based
  • Matrix appropriate samples include basic and specialty urine chemistry analytes
  • 12-month cycle
  • Submit results for the appropriate sample every month
  • 12 x 10 mL
Analytes
Albumin
Albumin-to-Creatinine Ratio
Bilirubin
Blood/Hemoglobin
Creatinine
Glucose
Ketones
Leukocytes
Nitrite
pH
Pregnancy (hCG)
Protein (Total)
Protein-to-Creatinine Ratio
Specific Gravity
Urobilinogen


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications

Catalog Number
12000810

Kit Configuration
12 x 2 mL

Insert »

EQAS Blood Typing 2

EQAS Blood Typing 2
EQAS Blood Gas Program is a monthly external quality assessment program for the reporting of routine blood gas, electrolytes, glucose, lactate and magnesium by blood gas, ion selection electrode (ISE) and biosensor instrumentation.
  • Liquid, aqueous samples
  • Comprehensive menu for external assessment of laboratory performance of Blood Gas, Electrolytes, Glucose, Lactate and Magnesium
  • 12-month cycle
Analytes
Calcium (Ionized) 
Chloride
Glucose
Lactate (Lactic Acid)
Magnesium
pH
pCO2
pO2
Potassium
Sodium


User Documentation
EQAS User Guide
Order Form / Enrollment Document

Customer Notifications
February 26, 2014: Results outside the assay range & UR Codes

Catalog Number
BC31

Kit Configuration
12x2.5mL

Order/Enroll »

Insert »